Identification of Distant Metastases From Recurrent Gliosarcoma Using Whole-Body 18F-FDG PET/CT
Standard
Identification of Distant Metastases From Recurrent Gliosarcoma Using Whole-Body 18F-FDG PET/CT. / Unterrainer, Marcus; Ruf, Viktoria; Cyran, Clemens C; Brendel, Matthias; Thon, Niklas; Herms, Jochen; Schüller, Ulrich; Tonn, Joerg-Christian; Bartenstein, Peter; Albert, Nathalie Lisa.
in: CLIN NUCL MED, Jahrgang 44, Nr. 11, 11.2019, S. 923-924.Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › Andere (Vorworte u.ä.) › Forschung
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - Identification of Distant Metastases From Recurrent Gliosarcoma Using Whole-Body 18F-FDG PET/CT
AU - Unterrainer, Marcus
AU - Ruf, Viktoria
AU - Cyran, Clemens C
AU - Brendel, Matthias
AU - Thon, Niklas
AU - Herms, Jochen
AU - Schüller, Ulrich
AU - Tonn, Joerg-Christian
AU - Bartenstein, Peter
AU - Albert, Nathalie Lisa
N1 - Editorial Material
PY - 2019/11
Y1 - 2019/11
N2 - A 51-year-old man presented with recurrent gliosarcoma and increasing cough over the last months. On F-FDG PET/CT, solid lung masses with high F-FDG uptake were present. A biopsy taken from a lung lesion indicated distant metastases from gliosarcoma. Gliosarcoma, a rare malignant central nervous system tumor, presents with extracranial metastases in only less than 10%. As highlighted by this case, F-FDG PET/CT can be used for whole-body staging in patients with metastatic brain tumor. Vice versa, highly F-FDG-avid lung lesions in patients with brain tumors should lead to distant metastases as differential diagnosis despite their rare occurrence.
AB - A 51-year-old man presented with recurrent gliosarcoma and increasing cough over the last months. On F-FDG PET/CT, solid lung masses with high F-FDG uptake were present. A biopsy taken from a lung lesion indicated distant metastases from gliosarcoma. Gliosarcoma, a rare malignant central nervous system tumor, presents with extracranial metastases in only less than 10%. As highlighted by this case, F-FDG PET/CT can be used for whole-body staging in patients with metastatic brain tumor. Vice versa, highly F-FDG-avid lung lesions in patients with brain tumors should lead to distant metastases as differential diagnosis despite their rare occurrence.
U2 - 10.1097/RLU.0000000000002790
DO - 10.1097/RLU.0000000000002790
M3 - Other (editorial matter etc.)
C2 - 31584491
VL - 44
SP - 923
EP - 924
JO - CLIN NUCL MED
JF - CLIN NUCL MED
SN - 0363-9762
IS - 11
ER -